Renee Maria Saliby (@reneesaliby) 's Twitter Profile
Renee Maria Saliby

@reneesaliby

Incoming PGY1 @YaleIMed | Postdoctoral GU Oncology Research Fellow @DanaFarber | MD '2021, MSc '2019 @USJLiban 🏎️🎾📖

ID: 298465857

calendar_today14-05-2011 11:00:25

2,2K Tweet

1,1K Followers

2,2K Following

Soki Kashima (@kashimamdphd) 's Twitter Profile Photo

I am excited to begin with my FY23 CDMRP KCRP Fellowship Award. Would appreciate my mentor David Braun for having me this amazing opportunity and wonderful projects. I thrilled to attack underlying resistant mechanisms in the aRCC. Sokuになってるけど😅↓ x.gd/jY8Lr

Srinivas Viswanathan (@srviswanathan) 's Twitter Profile Photo

Our study on sex differences in Xp11 translocation renal cell carcinoma is out Cell! We ascribe a genetic basis to the female bias in tRCC, which is driven by a translocation of the TFE3 gene on the X chromosome. w Zhang lab @danafarbernews bit.ly/4dtpNtP 🧵1/

Laura Bukavina (@laurabukavinamd) 's Twitter Profile Photo

We are hiring a postdoc .. Apply through link below Postdoctoral Fellow PhD- Microbiome and Immuno-oncology nature.com/naturecareers/…

We are hiring a postdoc .. Apply through link below Postdoctoral Fellow PhD- Microbiome and Immuno-oncology nature.com/naturecareers/…
Yale Urology (@yale_urology) 's Twitter Profile Photo

#ICYMI... Yale #researchers, including David Braun, analyzed clinical data from 734 patients who had the same diagnosis of clear cell #kidneycancer, received the same therapy yet had different outcomes. Learn more➡️tinyurl.com/ym7dyzjr Yale Cancer Center|Smilow Cancer Hospital|Yale School of Medicine

Toni Choueiri, MD (@drchoueiri) 's Twitter Profile Photo

1/ Results from #LITESPARK-005 are out NEJM! The phase 3 trial that led to HIF-2 inhibitor Belzutifan (BEL) U.S. FDA approval Dec 2023 in pretreated pts w/ #ccRCC. Presentation #ESMO24 @myEsmo Check it out: nejm.org/doi/full/10.10…

1/ Results from #LITESPARK-005 are out <a href="/NEJM/">NEJM</a>! 
The phase 3 trial that led to HIF-2 inhibitor Belzutifan (BEL) <a href="/US_FDA/">U.S. FDA</a> approval Dec 2023 in pretreated pts w/ #ccRCC. 
Presentation #ESMO24 @myEsmo

Check it out: nejm.org/doi/full/10.10…
GU Oncology Now (@guoncologynow) 's Twitter Profile Photo

🎙️ #ICYMI: We sat down with Bradley McGregor to discuss his journey from early influences and mentors to his current role at Dana-Farber. 📺 Watch Here: buff.ly/3Ma6h9W

OncLive.com (@onclive) 's Twitter Profile Photo

Time to next therapy was strongly associated with OS in patients with metastatic RCC previously treated with ICI-based therapy, prompting further investigation into this potentially meaningful intermediate trial end point. Renee Maria Saliby Dana-Farber #kcsm onclive.com/view/time-to-n…

Time to next therapy was strongly associated with OS in patients with metastatic RCC previously treated with ICI-based therapy, prompting further investigation into this potentially meaningful intermediate trial end point. <a href="/ReneeSaliby/">Renee Maria Saliby</a> <a href="/DanaFarber/">Dana-Farber</a> #kcsm onclive.com/view/time-to-n…
joaquim bellmunt (@oncobellmunt) 's Twitter Profile Photo

💫Proud of learning from negative trials. “Induction avelumab followed by chemoimmunotherapy and maintenance vs chemo alone as f1st line therapy in cis-ineligible mUC (INDUCOMAIN): a randomized phase II study” is out⚡️#rodriguez-vida Bego PValderrama SOGUG Dana-Farber Lank Center for Genitourinary Oncology Dana-Farber

💫Proud of learning from negative trials. “Induction avelumab followed by chemoimmunotherapy and maintenance vs chemo alone as f1st line therapy in cis-ineligible mUC (INDUCOMAIN): a randomized phase II study” is out⚡️#rodriguez-vida <a href="/begopval/">Bego PValderrama</a> <a href="/sogug1/">SOGUG</a> <a href="/DanaFarber_GU/">Dana-Farber Lank Center for Genitourinary Oncology</a> <a href="/DanaFarber/">Dana-Farber</a>
Formula 1 (@f1) 's Twitter Profile Photo

HE WINS IN MONZA!!! 🇮🇹 IT'S CHARLES LECLERC FOR FERRARI AT THEIR HOME RACE - AGAIN! 🏆👏 STUNNING, SIMPLY STUNNING! #F1 #ItalianGP

HE WINS IN MONZA!!! 🇮🇹

IT'S CHARLES LECLERC FOR FERRARI AT THEIR HOME RACE - AGAIN! 🏆👏

STUNNING, SIMPLY STUNNING!

#F1 #ItalianGP
Jacob Berchuck (@jberchuck) 's Twitter Profile Photo

🚀 Excited to share that I’ve joined Emory School of Medicine & Winship Cancer Institute of Emory University to launch The Berchuck Lab. Our research is focused on using liquid biopsy to improve outcomes for people living with cancer. We’re hiring for several key roles! Learn more & apply: theberchucklab.org

Carolina Alves Costa Silva, MD, PhD (@carolinaalvesc5) 's Twitter Profile Photo

I had the opportunity to represent #ClinicObiome Gustave Roussy as a partner of the #HumanMicrobiomeAction EU Project. Beyond innovative translational projects, we advocate for the acknowledgement of consensus and requirements in the microbiome field. 🔎 thelancet.com/journals/lanmi…